The fund invests in technologies such as gene therapy, RNS, antibodies and proteins as well as disease areas of cancer, rare disease, neurology and CVD.
https://www.google.com/url?rct=j&sa=t&url=https://www.proactiveinvestors.co.uk/companies/news/958166/rtw-investments--a-full-life-cycle-global-firm-targeting-most-innovative-subsectors-in-healthcare--958166.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGHKdt1o33R3vTtvi1UUOyxWFj_3Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.